In-depth: What the approval of flucytosine means for the treatment of cryptococcal meningitis in SA
After seemingly endless delays, a critically important drug for the treatment of cryptococcal meningitis was recently approved in South Africa. Yet, while the approval of flucytosine was a major step forward, much more still needs to be done to ensure wide availability of this life-saving medicine for the second leading killer of people living with HIV. Catherine Tomlinson unpacks the details.
